Form 4 for AQST Aquestive Therapeutics, Inc.

Accepted 2022-06-10 00:00:00 ET · period of report 2022-06-08 · accession 0001628280-22-016871 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-06-10	2022-06-08	AQST	BRAENDER LORI J	GC	P - Purchase	$0.96	+13.8K	38.8K	+55%	+$13.2K
D	2022-06-10	2022-06-08	AQST	BRAENDER LORI J	GC	P - Purchase	$0.13	+13.8K	13.8K	New	+$1,789

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-06-08	P	A	13,761	$0.96	38,761	D	—	—	(F1) Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13.
2	Derivative	Warrant (Right to Buy)	2022-06-08	P	A	13,761	$0.13	13,761	D	$0.96 · 2022-12-08 to 2027-06-08	13,761 Common Stock	(F1) Each share of common stock sold to the Reporting Person was sold together with one warrant to purchase one share of common stock at a price per share of $1.09 per share and warrant, of which the price per share of common stock was deemed to be $0.96 and the price per warrant was deemed to be $0.13.